Loading viewer...
investor_presentation
Format: PDF investor_presentation
Intel investor presentation dated October 2018.
EARNINGS Presentation2Disclosures
This presentation contains non -GAAP financial measures relating to our performance. You can find the reconciliation of these me asures to
the most directly comparable GAAP financial measure in the Appendix at the end of this presentation. The non -GAAP financial meas ures
disclosed by Intel should not be considered a substitute for, or superior to, the financial measures prepared in accordance w ithGAAP. Please
refer to “Explanation of Non -GAAP Measures” in Intel's quarterly earnings release for a detailed explanation of the adjustments made to the
comparable GAAP measures, the ways management uses the non -GAAP measures and the reasons why management believes the non -GAAP
measures provide investors with useful supplemental information.
Statements in this presentation that refer to business outlook, future plans and expectations are forward -looking statements tha t involve a
number of risks and uncertainties. Words such as "anticipates," "expects," "intends," "goals," "plans," "believes," "seeks," "estimates,"
"continues," "may," "will," “would,” "should," “could,” and variations of such words and similar expressions are intended to identify such
forward -looking statements. Statements that refer to or are based on estimates, forecasts, projections , uncertain events or assumptions,
including statements relating to total addressable market (TAM) or market opportunity and anticipated trends in our businesses or the
markets relevant to them, also identify forward -looking statements. Such statements are based on management's expectations as of October
25, 2018 and involve many risks and uncertainties that could cause actual results to differ materially from those expressed o r implied in these
forward -looking statements. Important factors that could cause actual results to differ materially from the company's expectatio ns are set
forth in Intel's earnings release dated October 25, 2018, which is included as an exhibit to Intel’s Form 8 -K furnished to the S EC on such date.
Additional information regarding these and other factors that could affect Intel's results is included in Intel's SEC filings , including the
company's most recent reports on Forms 10 -K and 10 -Q. Copies of Intel's Form 10 -K, 10 -Q and 8 -K reports may be obtained by visi ting our
Investor Relations website at www.intc.com or the SEC's website at www.sec.gov.
All information in this presentation reflects management’s views as of October 25, 2018. Intel does not undertake, and expre ssly disclaims
any duty, to update any statement made in this presentation, whether as a result of new information, new developments or othe rwise, except
to the extent that disclosure may be required by law.3Q3’18 Executive Summary
•Gaining share in an expanded >$300B TAM… All time record revenue of $19.2B
•Customer preference for Intel’s leadership performance driving strong mix and records
across CCG, DCG, IOTG, NSG, and MBLY
Preview truncated — download the full document for the complete content.
conference
12 Pages
investor_presentation
70 Pages
Genius Sports
Regeneron Pharmaceuticals Investor Presentation — May 2024
investor_presentationinvestor_presentation
32 Pages
Regeneron Pharmaceuticals, Inc.